Pharmacokinetics of HIV therapies in pregnant patients: an update-Reference-Cited by-同舟云学术

Pharmacokinetics of HIV therapies in pregnant patients: an update

Published:2020-04-19 Issue:6 Volume:16 Page:449-461
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Neary Megan¹,Owen Andrew¹,Olagunju Adeniyi¹²

Affiliation:

1. Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK

2. Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2020.1754792

Reference163 articles.

1. Harvey KM Adherence to highly active antiretroviral therapy (HAART) among HIV-infected perinatal clinic attendees and the impact on mother to child (MTCT) transmission of HIV in South East regional health authority (SERHA), Jamaica. 2017.

2. Prevention of Mother-to-Child HIV Transmission in Resource-Poor Countries

3. WHO. PMTCT strategic vision: preventing mother-to-child transmission of HIV to reach the UNGASS and millennium development goals 2010.

4. WHO. HIV/AIDs data and statistics. 2018. Available from: https://www.who.int/hiv/data/en/

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and placental transfer of dolutegravir in pregnancy;Journal of Antimicrobial Chemotherapy;2021-10-07

2. HIV in pregnancy: Mother-to-child transmission, pharmacotherapy, and toxicity;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2021-10